LyGDl functions in cancer metastasis by anchoring Rho proteins to the cell membrane

被引:33
作者
Ota, T
Maeda, M
Suto, S
Tatsuka, M [1 ]
机构
[1] Kanazawa Med Univ, Med Res Inst, Div Mol Oncol & Virol, Uchinada, Ishikawa 9200293, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima 7348553, Japan
关键词
RhoGDl; metastasis; ERM proteins; Rac; colon cancer;
D O I
10.1002/mc.20006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rho family GTPases play an important role in a number of processes related to metastasis, and RhoGDP dissociation, inhibitors (RhoGDIs) regulate Rho family proteins. We cloned genomic DNA from colon carcinoma SW480 cells capable of transforming nonmetastatic ras-transformed 1-1ras1000 cells into metastatic cells. This DNA contained a truncated human ras homolog gene family GDP dissociation inhibitor beta (ARHGDIB) gene, resulting in a C-terminal truncated form of LyGDI (DeltaC-LyGDI, 166-201 deletion), a member of the RhoGDIs. The stable expression of DeltaC-LyGDI induced pulmonary metastasis in 1-1ras1000 cells, whereas expression of full-length LyGDI did not induce metastasis. DeltaC-LyGDI was preferentially localized in the membrane, detected in a NP-40-insoluble fraction, and co-purified with radixin, moesin, Rac1, Cdc42, and RhoA. In DeltaC-LyGDI transfectant, an activation state of Rac1 was elevated and DeltaC-LyGDI was associated with Rac1-GTP. In keeping with the observed localization of Rac1 to the cell membrane and the elevated level of Rac1-GTP, DeltaC-LyGDI transfectants were found to be more invasive than mock transfectant. These results suggest that LyGDI functions in the cell membrane to afford spatial regulation of Rho family GTPase signaling through ezrin radixin moesin (ERM) proteins during metastasis. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:206 / 220
页数:15
相关论文
共 66 条
[51]   RHO AS A REGULATOR OF THE CYTOSKELETON [J].
TAKAI, Y ;
SASAKI, T ;
TANAKA, K ;
NAKANISHI, H .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (06) :227-231
[52]  
Tatsuka M, 1997, INT J CANCER, V71, P88, DOI 10.1002/(SICI)1097-0215(19970328)71:1<88::AID-IJC15>3.3.CO
[53]  
2-8
[54]  
Tatsuka M, 1996, MOL CARCINOGEN, V15, P300, DOI 10.1002/(SICI)1098-2744(199604)15:4<300::AID-MC7>3.0.CO
[55]  
2-J
[56]   ELONGATION FACTOR-1-ALPHA GENE DETERMINES SUSCEPTIBILITY TO TRANSFORMATION [J].
TATSUKA, M ;
MITSUI, H ;
WADA, M ;
NAGATA, A ;
NOJIMA, H ;
OKAYAMA, H .
NATURE, 1992, 359 (6393) :333-336
[57]   AIM-1: a mammalian midbody-associated protein required for cytokinesis [J].
Terada, Y ;
Tatsuka, M ;
Suzuki, F ;
Yasuda, Y ;
Fujita, S ;
Otsu, M .
EMBO JOURNAL, 1998, 17 (03) :667-676
[58]  
Thiede B, 2002, PROTEOMICS, V2, P996, DOI 10.1002/1615-9861(200208)2:8<996::AID-PROT996>3.0.CO
[59]  
2-3
[60]   Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIα [J].
Togawa, A ;
Miyoshi, J ;
Ishizaki, H ;
Tanaka, M ;
Takakura, A ;
Nishioka, H ;
Yoshida, H ;
Doi, T ;
Mizoguchi, A ;
Matsuura, N ;
Niho, Y ;
Nishimune, Y ;
Nishikawa, S ;
Takai, Y .
ONCOGENE, 1999, 18 (39) :5373-5380